Insider · CIK 0001781450

Bashan Dror

Reports to the SEC for 1 company · CARMIEL

sec.gov

Transactions

Companies

Filings

CIK

0001781450

Forms 4 and 5

Insider transactions

15 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-03	PLXProtalix BioTherapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, PRESIDENT AND CEO	AAward	+320K sh	—	—	320,000
2026-09-03	PLXProtalix BioTherapeutics, Inc. · Restricted Stock UnitsA Award	Director, PRESIDENT AND CEO	AAward	+160K sh	—	—	160,000
2025-12-19	PLXProtalix BioTherapeutics, Inc.P Purchase	Director, PRESIDENT AND CEO	PPurchase	+56K sh	$1.81	+$101K	188,516
2025-09-03	PLXProtalix BioTherapeutics, Inc.A Award	Director, PRESIDENT AND CEO	AAward	+195K sh	—	—	2,344,418
2025-09-03	PLXProtalix BioTherapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, PRESIDENT AND CEO	AAward	+340K sh	—	—	340,000
2024-04-01	PLXProtalix BioTherapeutics, Inc.A Award	Director, PRESIDENT AND CEO	AAward	+264K sh	—	—	2,149,418
2023-10-19	PLXProtalix BioTherapeutics, Inc.P Purchase	Director, PRESIDENT AND CEO	PPurchase	+16.1K sh	$1.41	+$22.7K	132,516
2023-10-19	PLXProtalix BioTherapeutics, Inc.P Purchase	Director, PRESIDENT AND CEO	PPurchase	+48.4K sh	$1.40	+$67.7K	116,387
2023-08-15	PLXProtalix BioTherapeutics, Inc.A Award	Director, PRESIDENT AND CEO	AAward	+800K sh	—	—	1,885,458
2022-09-07	PLXProtalix BioTherapeutics, Inc. · Stock Options (Right to Buy)A Award	Director, PRESIDENT AND CEO	AAward	+750K sh	—	—	750,000
2022-04-11	PLXProtalix BioTherapeutics, Inc.P Purchase	Director, PRESIDENT AND CEO	PPurchase	+68K sh	$1.50	+$102K	68,000
2022-02-25	PLXProtalix BioTherapeutics, Inc.A Award	Director, PRESIDENT AND CEO	AAward	+638K sh	—	—	1,085,458
2020-08-11	PLXProtalix BioTherapeutics, Inc.A Award	Director, PRESIDENT AND CEO	AAward	+448K sh	—	—	447,927
2020-08-11	PLXProtalix BioTherapeutics, Inc.A Award	Director, PRESIDENT AND CEO	AAward	+448K sh	—	—	447,927
2019-06-30	PLXProtalix BioTherapeutics, Inc. · Stock Options (Right to Buy)A Award	Director, PRESIDENT AND CEO	AAward	+1.6M sh	—	—	1,600,000

Recent filings

Accepted (ET)
Sep 44
Bashan Dror0001781450-26-000002
SEC(opens sec.gov)
Dec 234
Bashan Dror0001781450-25-000005
SEC(opens sec.gov)
Sep 44
Bashan Dror0001415889-25-023700
SEC(opens sec.gov)
Apr 34
Bashan Dror0001415889-24-010099
SEC(opens sec.gov)
Oct 204
Bashan Dror0001415889-23-014454
SEC(opens sec.gov)
Aug 174
Bashan Dror0001104659-23-093073
SEC(opens sec.gov)
Sep 94
Bashan Dror0001104659-22-098949
SEC(opens sec.gov)
Apr 134
Bashan Dror0001104659-22-045488
SEC(opens sec.gov)
Feb 284
Bashan Dror0001104659-22-028157
SEC(opens sec.gov)
Aug 144/A
Bashan Dror0001104659-20-095623
SEC(opens sec.gov)
Aug 134
Bashan Dror0001104659-20-094753
SEC(opens sec.gov)
Jul 24
Bashan Dror0001144204-19-033654
SEC(opens sec.gov)

Companies

Protalix BioTherapeutics, Inc.Director, PRESIDENT AND CEOPLX

Address

C/O PROTALIX BIOTHERAPEUTICS, INC. 2 SNUNIT STREET SCIENCE PARK, POB 455

CARMIEL, 2161401